2[2]Hacke W,Kaste M,Bogousslavsky J,et al.European stroke Initiative executive committee and the EUSI writing committee.European stroke initiative recommendations for stroke management update 2003[J].Cerebrovasc Dis,2003,16:311-337. 被引量：1
3[3]Sacco RL,Adams R,Albers G,et al.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack:a statement for healthcare professionals from the American heart association/American stroke association council on stroke:cosponsored by the council on cardiovascular radiology and intervention:the American academy of neurology affirms the value of this guidelines[J].Stroke,2006,37:577-617. 被引量：1
4[4]Holloway RG,Benesch C,Rush S.Stroke prevention:narrowing the evidence-practice gap[J].Neurology,2000,54:1899-1906. 被引量：1
5[5]Rudd AG,Lowe D,Hoffman A,et al.Secondary prevention for stroke in the United Kingdom:results from the national sentinel audit of Stroke[J].Age and Ageing,2004,33:280-286. 被引量：1
6[6]Ovbiagele B,Saver JL,Bang H,et al.Statin treatment and adhe-rence to national cholesterol guidelines after ischemic stroke[J].Neurology,2006,66:1164-1170. 被引量：1
7[7]Deplanque D,Leys D,Parnetti L,et al.Secondary prevention of stroke in patients with atrial fibrillation:factors influencing the prescription of oral anticoagulation at discharge[J].Cerebrovasc Dis,2006,21:372-379. 被引量：1
10[10]Schryver D,van Gijn ELLM.,Kappelle J,et al.Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischemic stroke[J].J Neurol,2005:1316-1321. 被引量：1
4Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.Antithrombotic Trialists′ Collaboration. BMJ,2002,324:71-86. 被引量：1
5Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation Ⅲ randomised clinical trial.Lancet,1996,348:633-638. 被引量：1
6Rudd AG, Lowe D, Hoffman A, et al. Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke.Age Ageing,2004,33:280-286. 被引量：1
7Sappok T, Faulstich A, Stuckert E, et al.Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke, 2001,32:1884-1889. 被引量：1
8Hamann GF, Weimar C, Glahn J, et al.Adherence to secondary stroke prevention strategies results from the German Stroke Data Bank.Cerebrovasc Dis, 2003,15:282-288. 被引量：1
9Wolf PA, Clagett GP, Easton JD, et al.Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association.Stroke,1999,30:1991-1994. 被引量：1
10Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet,2004,364:331-337. 被引量：1
8Wang YJ, Zhang SM, Zhang L, et al. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010 [ J]. CNS Neurosci Ther,2012, (2) 18:93-101. 被引量：1
10Rohwell PM, Coull A J, Giles MF, et al, for the Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, and risk factors in Oxfordshire, UK from 1981 to 2004 ( Oxford Vascular Study) [ J ]. Lancet,2004, 363 ( 9425 ) : 1925-1933. 被引量：1
